Dr Ray O’Connor continues his look at recent clinical papers on stroke, including clinical symptoms or signs associated with ...
Promising results were recently reported for the ALIAS (Albumin in Acute Stroke) Pilot Trial—a phase I, open-label, dose-escalation study investigating use of high-dose human albumin (ALB) for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results